BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
31302798
Number of visits today
5088
Number of downloads
13861949
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Chen F, Yang J, Fang M, Wu Y, Su D, Sheng Y. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer. J Clin Lab Anal 2022;:e24302. [PMID: 35229919 DOI: 10.1002/jcla.24302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Yue Q, Cao F, Li Y, Wei Y. Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients. Sci Rep 2022;12:11268. [PMID: 35787661 DOI: 10.1038/s41598-022-15209-3] [Reference Citation Analysis]
2 Zheng Y, Xu J, Lin J, Lin Y, Chen G. A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/8003525] [Reference Citation Analysis]
3 Song H, Li T, Sheng J, Li D, Liu X, Xiao H, Yu H, Liu W, Wang K, Chen Y. Necroptosis-Related miRNA Biomarkers for Predicting Overall Survival Outcomes for Endometrial Cancer. Front Genet 2022;13:828456. [PMID: 35719379 DOI: 10.3389/fgene.2022.828456] [Reference Citation Analysis]
4 Zhang J, He X, Hu J, Li T. Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma. Front Genet 2022;13:920350. [PMID: 35754848 DOI: 10.3389/fgene.2022.920350] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345